Health system, surveillance and the COVID-19 pandemic response in France.
Livia Angeli SilvaJoão Vitor Pereira Dos SantosMonique Azevedo EsperidiãoPublished in: Ciencia & saude coletiva (2023)
France was the first European country to confirm cases of COVID-19, being one of the most affected by the pandemic in the first wave. This case study analyzed the measures adopted by the country in the fight against COVID-19 in 2020 and 2021, correlating it to the characteristics of its health and surveillance system. As a welfare state, it relied on compensatory policies and protection of the economy, as well as increased investments in health. There were weaknesses in the preparation and delay in the implementation of the coping plan. The response was coordinated by the national executive power, adopting strict lockdowns in the first two waves, mitigating restrictive measures in the other waves, after the increase in vaccination coverage and in the face of population resistance. The country faced problems with testing, case and contact surveillance and patient care, especially in the first wave. It was necessary to modify the health insurance rules to expand coverage, access and better articulation of surveillance actions. It indicates lessons learned about the limits of its social security system, but also the potential of a government with a strong response capacity in the financing of public policies and regulation of other sectors to face the crisis.
Keyphrases
- public health
- coronavirus disease
- health insurance
- healthcare
- sars cov
- mental health
- affordable care act
- global health
- quality improvement
- depressive symptoms
- risk assessment
- working memory
- emergency department
- mass spectrometry
- social support
- drug induced
- human health
- high resolution
- social media
- molecularly imprinted
- solid phase extraction